Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Etoposide and temozolomide in combination for the treatment of progressive small-cell lung cancer central nervous system metastases: two cases.
Temozolomide and/or Erlotinib in the Treatment of Lung Cancer Patients With Progressive Central Nervous System Metastases.
C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype.
Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer.
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer. Oncotarget. 2016 Oct 11; 7(41):66880-66891.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Circulating Tumor DNA
Disease-Free Survival
DNA, Neoplasm
ErbB Receptors
Female
High-Throughput Nucleotide Sequencing
Humans
Liquid Biopsy
Lung
Lung Neoplasms
Male
Middle Aged
Mutation
Neoplastic Cells, Circulating
Young Adult
authors with profiles
Ravi Salgia